|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn643885888 |
003 |
OCoLC |
005 |
20231117033150.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100626s1989 enka ob 100 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OPELS
|d OCLCQ
|d E7B
|d IDEBK
|d OCLCQ
|d OCLCF
|d UIU
|d OCLCO
|d OCLCQ
|d OCLCA
|d LEAUB
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCL
|
019 |
|
|
|a 648496974
|a 974619552
|a 988555889
|
020 |
|
|
|z 0124507409
|
020 |
|
|
|z 9780124507401
|
035 |
|
|
|a (OCoLC)643885888
|z (OCoLC)648496974
|z (OCoLC)974619552
|z (OCoLC)988555889
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a RB43
|
060 |
|
4 |
|a W1
|b PH255 v.1 1989
|
060 |
|
4 |
|a WD 375
|b C641 1988
|
082 |
0 |
4 |
|a 616.07/582
|2 19
|
245 |
0 |
0 |
|a Clinical impact of bone and connective tissue markers /
|c edited by E. Lindh and J.I. Thorell.
|
260 |
|
|
|a London ;
|a San Diego :
|b Academic Press,
|c �1989.
|
300 |
|
|
|a 1 online resource (xi, 349 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Pharmacia Diagnostics clinical symposia ;
|v 1
|
504 |
|
|
|a Includes bibliographical references.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
520 |
|
|
|a For many years, biochemical tests have been widely used for the diagnosis, classification, and monitoring of bone and connective tissue disease. However, shortcomings in terms of the specificity and sensitivity of such tests have prompted continual questioning about their clinical usefulness. This book, based on a meeting organized jointly by the University of Uppsala and Pharmacia Diagnostics AB, reviews our current understanding of basic bone and connective tissue biochemistry and the clinical role of biochemical markers specific to related diseases, with special reference to rheumatoid arthritis and osteoporosis.
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Cytodiagnosis.
|
650 |
|
0 |
|a Biochemical markers.
|
650 |
|
0 |
|a Bones
|x Diseases.
|
650 |
|
0 |
|a Connective tissues
|x Diseases.
|
650 |
|
2 |
|a Biomarkers
|0 (DNLM)D015415
|
650 |
|
2 |
|a Bone Diseases
|0 (DNLM)D001847
|
650 |
|
2 |
|a Connective Tissue Diseases
|0 (DNLM)D003240
|
650 |
|
2 |
|a Cytodiagnosis
|0 (DNLM)D003581
|
650 |
|
6 |
|a Cytodiagnostics.
|0 (CaQQLa)201-0040228
|
650 |
|
6 |
|a Marqueurs biologiques.
|0 (CaQQLa)201-0177920
|
650 |
|
6 |
|a Os
|x Maladies.
|0 (CaQQLa)201-0000241
|
650 |
|
6 |
|a Tissu conjonctif
|x Maladies.
|0 (CaQQLa)201-0036460
|
650 |
|
7 |
|a Connective tissues
|x Diseases.
|2 fast
|0 (OCoLC)fst00875347
|
650 |
|
7 |
|a Bones
|x Diseases.
|2 fast
|0 (OCoLC)fst00836004
|
650 |
|
7 |
|a Biochemical markers.
|2 fast
|0 (OCoLC)fst00831950
|
650 |
|
7 |
|a Cytodiagnosis.
|2 fast
|0 (OCoLC)fst00886255
|
653 |
|
|
|a Medicine
|a Diagnosis
|a Use of cell markers
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Lindh, E.
|q (Erik)
|
700 |
1 |
|
|a Thorell, Jan I.,
|d 1934-
|
776 |
0 |
8 |
|i Print version:
|w (OCoLC)21198657
|
830 |
|
0 |
|a Pharmacia Diagnostics clinical symposia ;
|v 1.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780124507401
|z Texto completo
|